Koninklijke Philips Gross Profit 2010-2024 | PHG

Koninklijke Philips annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Koninklijke Philips gross profit for the quarter ending September 30, 2024 was $2.206B, a 19.67% increase year-over-year.
  • Koninklijke Philips gross profit for the twelve months ending September 30, 2024 was $8.372B, a 0.37% decline year-over-year.
  • Koninklijke Philips annual gross profit for 2024 was $8.411B, a 4.34% increase from 2023.
  • Koninklijke Philips annual gross profit for 2023 was $8.061B, a 6.35% increase from 2022.
  • Koninklijke Philips annual gross profit for 2022 was $7.58B, a 10.62% decline from 2021.
Koninklijke Philips Annual Gross Profit
(Millions of US $)
2024 $8,411
2023 $8,061
2022 $7,580
2021 $8,480
2020 $10,031
2019 $9,940
2018 $10,101
2017 $9,246
2016 $11,743
2015 $10,944
2014 $10,908
2013 $12,869
2012 $12,101
2011 $12,044
2010 $12,677
2009 $11,267
Koninklijke Philips Quarterly Gross Profit
(Millions of US $)
2024-09-30 $2,206
2024-06-30 $2,142
2023-06-30 $2,139
2023-03-31 $1,885
2022-06-30 $1,843
2021-06-30 $2,156
2020-06-30 $2,016
2019-06-30 $2,389
2018-06-30 $2,392
2017-06-30 $2,118
2016-12-31 $3,472
2016-09-30 $2,904
2016-06-30 $2,867
2016-03-31 $2,500
2015-12-31 $3,101
2015-09-30 $2,695
2015-06-30 $2,760
2015-03-31 $2,388
2014-12-31 $2,730
2014-09-30 $2,422
2014-06-30 $2,991
2014-03-31 $2,766
2013-12-31 $3,906
2013-09-30 $3,122
2013-06-30 $3,065
2013-03-31 $2,775
2012-12-31 $3,851
2012-09-30 $3,265
2012-06-30 $2,509
2012-03-31 $2,783
2011-12-31 $2,950
2011-09-30 $2,735
2011-06-30 $2,940
2011-03-31 $3,301
2010-12-31 $3,754
2010-09-30 $3,011
2010-06-30 $2,911
2010-03-31 $3,019
2009-12-31 $5,210
2009-09-30 $2,898
2009-06-30 $1,586
2009-03-31 $2,148
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.587B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.530B 28.20
Boston Scientific (BSX) United States $156.880B 39.27
Stryker (SYK) United States $150.466B 31.46
EssilorLuxottica (ESLOY) France $133.537B 0.00
Medtronic (MDT) Ireland $110.863B 16.19
Lonza Group Ag (LZAGY) Switzerland $49.634B 0.00
Haleon (HLN) United Kingdom $48.687B 27.69
ResMed (RMD) United States $36.905B 27.72
GE HealthCare Technologies (GEHC) United States $33.485B 15.90
Agilent Technologies (A) United States $32.436B 21.43
Terumo (TRUMY) Japan $27.642B 35.90
Insulet (PODD) United States $22.854B 89.71
Zimmer Biomet Holdings (ZBH) United States $19.181B 12.32
Baxter (BAX) United States $16.247B 12.13
Smith & Nephew SNATS (SNN) United Kingdom $12.648B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.231B 0.00
Bio-Rad Laboratories (BIO) United States $6.767B 23.55
Lantheus Holdings (LNTH) United States $5.621B 14.18
Prestige Consumer Healthcare (PBH) United States $4.402B 19.67
Perrigo (PRGO) Ireland $3.719B 9.43
Haemonetics (HAE) United States $3.532B 15.39
ICU Medical (ICUI) United States $3.480B 25.66
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.097B 25.73
QuidelOrtho (QDEL) United States $2.263B 15.56
GN Store Nord (GNNDY) Denmark $2.097B 17.37
LeMaitre Vascular (LMAT) United States $1.915B 42.81
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.435B 18.36
Kestra Medical Technologies (KMTS) United States $1.264B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.182B 26.59
BioLife Solutions (BLFS) United States $1.121B 0.00
InMode (INMD) Israel $1.020B 9.34
Phibro Animal Health (PAHC) United States $0.973B 12.44
CeriBell (CBLL) United States $0.649B 0.00
Evolus (EOLS) United States $0.625B 0.00
Owens & Minor (OMI) United States $0.570B 4.73
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.535B 0.00
Valneva SE (VALN) France $0.524B 0.00
Tilray Brands (TLRY) Canada $0.498B 0.00
Capricor Therapeutics (CAPR) United States $0.431B 0.00
Surmodics (SRDX) United States $0.409B 0.00
SNDL (SNDL) Canada $0.355B 0.00
Cresco Labs (CRLBF) United States $0.335B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
SEMPERIT AG HLD (SEIGY) Austria $0.321B 0.00
Canopy Growth (CGC) Canada $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.288B 51.30
Sanara MedTech (SMTI) United States $0.280B 0.00
Sanuwave Health (SNWV) United States $0.276B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.53
Cerus (CERS) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.251B 11.41
Verano Holdings (VRNOF) United States $0.235B 0.00
Biote (BTMD) United States $0.224B 6.31
High Tide (HITI) Canada $0.191B 0.00
Omeros (OMER) United States $0.187B 0.00
Brainsway (BWAY) Israel $0.187B 49.55
Quanterix (QTRX) United States $0.186B 0.00
Organigram Global (OGI) Canada $0.182B 0.00
OraSure Technologies (OSUR) United States $0.182B 0.00
Utah Medical Products (UTMD) United States $0.181B 14.58
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Exagen (XGN) United States $0.128B 0.00
FitLife Brands (FTLF) United States $0.128B 15.77
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.080B 10.32
Veru (VERU) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
Quipt Home Medical (QIPT) United States $0.061B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 13.35
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 30.86
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00